Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.

Authors

Jaime E. Hernandez, BioCryst Pharmaceuticals, Durham, NC
Joanne Grainger, BioCryst Pharmaceuticals, Durham, NC
Lone Simonsen, George Washington University
Phil Collis, BioCryst Pharmaceuticals, Durham, NC
William P. Sheridan, BioCryst Pharmaceuticals, Durham, NC
Laurel Edelman, SDI Health, LLC, Plymouth Meeting, PA

Document Type

Journal Article

Publication Date

9-2012

Journal

Influenza and other Respiratory Viruses

Volume

Volume 6, Issue 5

Inclusive Pages

305-308

Keywords

Antiviral Agents--administration & dosage; Clinical Laboratory Techniques--statistics & numerical data; Hospitalization--statistics & numerical data; Influenza A Virus; H1N1 Subtype--isolation & purification; Influenza; Human--epidemiology; Pandemics

Comments

This is an open access Pubmed Central article.

APA Citation

Hernandez, J. E., Grainger, J., Simonsen, L., Collis, P., Edelman, L., & Sheridan, W. P. (2012). Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other Respiratory Viruses, 6(5), 305-308.

Open Access

1